Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with Schistosoma japonicum
- PMID: 38767360
- PMCID: PMC11237810
- DOI: 10.1128/iai.00026-24
Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with Schistosoma japonicum
Abstract
Schistosomiasis is a serious public health problem, and previous studies found that liver function and hepatic cells are damaged. To evaluate the serum parameters of liver function and fibrosis in schistosomiasis patients infected with Schistosoma japonicum (Schistosoma J.) and analyze the correlations between liver function and serum fibrosis markers in patients infected with Schistosoma J., this retrospective study enrolled 133 patients. The study population was divided into four groups: healthy people control group (n = 20), chronic schistosomiasis without liver cirrhosis (CS) group (n = 21), schistosomiasis cirrhosis without hypoalbuminemia (SC-HA) group (n = 68), and schistosomiasis cirrhosis with hypoalbuminemia (SC +HA) group (n = 24). Clinical and laboratory data were collected for analysis. In the multiple comparison of abnormal rates of aspartate aminotransferase (AST) and total bilirubin (TBIL), the abnormal rate of the SC +HA group was significantly higher than that of the other three groups (P < 0.05), and the abnormal rate of γ-GT in the SC +HA group was significantly higher than that in the control group (P < 0.05). Multiple comparison results of serum levels of fibrosis markers showed that the SC group had a significantly higher level of indexes than other groups (P < 0.05). The levels of TGF-β1 in the CS group, SC-HA group and SC +HA group were significantly higher than those in the control group (P < 0.001). Our study demonstrated that the liver function and hepatic cells were damaged with the progression of liver disease in patients infected with Schistosoma J., and they played an important role in the occurrence and development of liver fibrosis.
Keywords: hepatocyte damage; liver fibrosis; liver function; schistosomiasis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Abnormal liver function in different patients with Schistosoma japonicum.Parasitol Res. 2015 Jan;114(1):85-90. doi: 10.1007/s00436-014-4163-7. Epub 2014 Oct 8. Parasitol Res. 2015. PMID: 25287714
-
Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum.World J Gastroenterol. 2008 May 14;14(18):2905-11. doi: 10.3748/wjg.14.2905. World J Gastroenterol. 2008. PMID: 18473419 Free PMC article.
-
Sodium butyrate ameliorates Schistosoma japonicum-induced liver fibrosis by inhibiting HMGB1 expression.Exp Parasitol. 2021 Dec;231:108171. doi: 10.1016/j.exppara.2021.108171. Epub 2021 Nov 2. Exp Parasitol. 2021. PMID: 34736899
-
Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis.Front Cell Infect Microbiol. 2022 Oct 28;12:1035765. doi: 10.3389/fcimb.2022.1035765. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36389166 Free PMC article. Review.
-
MicroRNA dysregulation in schistosomiasis-induced hepatic fibrosis: a systematic review.Expert Rev Mol Diagn. 2023 Mar;23(3):257-265. doi: 10.1080/14737159.2023.2182190. Epub 2023 Feb 26. Expert Rev Mol Diagn. 2023. PMID: 36803616
Cited by
-
Yinchenhao Decoction Combined with Praziquantel Ameliorates Inflammation and Hepatic Fibrosis in Schistosoma japonicum-Infected Mice.Curr Med Sci. 2025 Aug;45(4):944-956. doi: 10.1007/s11596-025-00089-1. Epub 2025 Jul 30. Curr Med Sci. 2025. PMID: 40736935
References
-
- Zhang W, Zhu J, Song X, Xu Z, Xue X, Chen X, Yang X, Li Y, Dong X, Zhou S, Li W, Qian Y, Liu F, Su C. 2015. An association of aquaporin-4 with the immunoregulation of liver pathology in mice infected with Schistosoma japonicum. Parasit Vectors 8:37. doi:10.1186/s13071-015-0650-7 - DOI - PMC - PubMed
-
- Lei ZL, Zheng H, Zhang LJ, Zhu R, Xu ZM, Xu J, Fu Q, Wang Q, Li SZ, Zhou XN. 2014. [Endemic status of schistosomiasis in People's Republic of China in 2013]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 26:591–597. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous